MedPath

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Phase 3
Completed
Conditions
Opioid-Related Disorders
Registration Number
NCT00078130
Lead Sponsor
University of Pennsylvania
Brief Summary

The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
223
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Opiate abstinence
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Mountain Manor

🇺🇸

Baltimore, Maryland, United States

Mercy Hospital

🇺🇸

Portland, Maine, United States

Duke Addictions Program

🇺🇸

Durham, North Carolina, United States

ASAP

🇺🇸

Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath